Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(S)-N-((6S,9S,12S,15S,18S,21S,24S,27S)-12-((1H-indol-3-yl)methyl)-1,31-diamino-6-((S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-ylcarbamoyl)-9,15-bis(4-aminobutyl)-24-sec-butyl-18-(3-guanidinopropyl)-21-(4-hydroxybenzyl)-1-imino-8,11,14,17,20,23,26-heptaoxo-2,7,10,13,16,19,22,25-octaazahentriacontan-27-yl)-6-amino-2-((2S,3S)-2-((S)-2-amino-4-methylpentanamido)-3-methylpentanamido)hexanamide
ID: ALA4791109
Chembl Id: CHEMBL4791109
PubChem CID: 162670672
Max Phase: Preclinical
Molecular Formula: C85H137N25O13
Molecular Weight: 1717.19
Molecule Type: Unknown
Associated Items: